Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Interleukin-2 × Clear all

Phase

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Breast Neoplasms 6 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid 2 Leukemia 2 Glioblastoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Select Advanced Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Follicular 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 18 pembrolizumab 10 Temozolomide 10 Specimen Handling 8 Bevacizumab 8 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Ipilimumab 5 Cyclophosphamide 5 Neuropsychological Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Radiation 3 Proton Therapy 3 Mental Status and Dementia Tests 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 binimetinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡